3 Most Active ‘Strong Buy’ Stocks with Market-Topping Gains — August 6, 2026
Shopify ($SHOP), Booking ($BKNG), and Eli Lilly ($LLY) were among the most active and best-performing stocks on Wednesday. More importantly, all th...
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 5,063,516 | $6,073,333,633 | +5% | 1.81% |
| 2. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 29,821 | $35,768,202 | -25% | 9.62% |
| 3. | Walleye Capital Will England | 28,457 | $34,132,180 | +38% | 0.12% |
| 4. | Navellier & Associates Louis Navellier | 26,077 | $31,277,395 | -6% | 2.48% |
| 5. | Bourgeon Capital John Zaro | 24,426 | $29,296,920 | +5% | 4.31% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,150.77 | 2,500 | $2,876,925.00 | 29,804 | 2026-06-10 | Filing | |
| $996.18 | 2,208 | $2,199,572.06 | 91,881,150 | 2026-05-06 | Filing | |
| $995.23 | 13,620 | $13,554,964.50 | 91,883,358 | 2026-05-06 | Filing | |
| $1,116.69 | 2,737 | $3,056,369.58 | 91,896,978 | 2026-01-07 | Filing | |
| $1,115.76 | 2,210 | $2,465,831.81 | 91,899,715 | 2026-01-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 90,376,978 | $108,400,858,723 | 100% | |
| 2. | 5,461,416 | $6,550,586,781 | 3.93% | |
| 3. | 4,783,459 | $5,737,424,031 | 0.94% | |
| 4. | 2,137,500 | $2,563,781,625 | 0.61% | |
| 5. | 1,895,765 | $2,273,837,414 | 1.3% |
News See All
Rumors Swirl That Eli Lilly (LLY) Will Split Its Stock After Blockbuster Earnings
The pharma giant hasn’t split its shares since 1997.
Novo Nordisk Stock (NVO) Recovers as Earnings Surprise to the Upside
The company beat Wall Street forecasts across the board.
LLY Earnings: Eli Lilly’s Stock Jumps on Blowout Financial Results
The company continues to dominate the obesity drug market.
Options Volatility and Implied Earnings Moves Today, August 05, 2026
Today, several major companies are expected to report earnings: Riot Platforms (RIOT), CVS Health (CVS), Eli Lilly & Co (LLY), Realty Income (O), W...
These Are the Stocks Reporting Earnings Today – August 5, 2026
Here’s a look at today’s key earnings reports from major publicly traded companies. Stock market investors will undoubtedly be watching closely for...
Earnings Standouts: 52 Stocks Outperforming Wall Street Estimates
Research by the Bank for International Settlements said that equity markets tend to already price in earnings expectations well before official results are announced.
3 Best Vanguard ETFs for Stress-Free Retirement Investing
Planning for retirement doesn’t have to mean picking dozens of investments. A few low-cost Vanguard ETFs can provide broad market exposure, steady ...
Is Eli Lilly (LLY) Still the Undisputed Leader in the $150 Billion Obesity Drug Market?
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Eli Lilly Stock (LLY) Is Down Nearly 10% Heading into Earnings. Time to Buy?
The company’s Q2 results will be the first to include sales of its obesity pill.
Hedge Fund Resource Center